In this piece, we will take a look at the five most promising small-cap stocks according to analysts. If you want to learn more about small cap investing, then you can check out 13 Most Promising Small-Cap Stocks According to Analysts.
5. 23andMe Holding Co. (NASDAQ:ME)
Latest Average Analyst Share Price Target: $1.95
Latest Share Price Percentage Upside: 121.59%
23andMe Holding Co. (NASDAQ:ME) is a small American firm that processes genetic tests for its customers. It was out with some great news for investors and cancer patients in December 2023 when the firm announced that it is expanding its ovarian cancer trial to add more patients.
After digging through 910 hedge funds for their Q3 2023 shareholdings, Insider Monkey found six 23andMe Holding Co. (NASDAQ:ME) shareholders. Out of these, the firm’s largest shareholder was Jim Simons’ Euclidean Capital through its $10 million investment.
Follow 23Andme Holding Co.
Follow 23Andme Holding Co.
4. Korro Bio, Inc. (NASDAQ:KRRO)
Latest Average Analyst Share Price Target: $116.67
Latest Share Price Percentage Upside: 130.98%
Korro Bio, Inc. (NASDAQ:KRRO) is a small biotechnology company that is developing gene editing medicines. Its shares are rated Buy on average and the average analyst share price target is $116.67. It’s also a relatively new entrant on the stock market, as the shares were made available for trading in November 2023 after a private placement of $117 million. Since then, the shares have gained a respectable 226% on the market.
3. Amarin Corporation plc (NASDAQ:AMRN)
Latest Average Analyst Share Price Target: $2.31
Latest Share Price Percentage Upside: 153.85%
Amarin Corporation plc (NASDAQ:AMRN) is an American firm developing treatments for people with heart diseases. 2023 has not been a great year for the firm either on the stock market or on the financial front. It has missed analyst EPS estimates in three of its four latest quarters, and the stock is down 23% year to date.
During 2023’s third quarter, 15 out of the 910 hedge funds tracked by Insider Monkey had held a stake in the firm. Amarin Corporation plc (NASDAQ:AMRN)’s biggest hedge fund investor is Derrick Tang’s Kynam Capital through its $11 million investment.
Follow Amarin Corp Plc (NASDAQ:AMRN)
Follow Amarin Corp Plc (NASDAQ:AMRN)
2. Senseonics Holdings, Inc. (NYSE:SENS)
Latest Average Analyst Share Price Target: $1.63
Latest Share Price Percentage Upside: 171.67%
Senseonics Holdings, Inc. (NYSE:SENS) is a medical devices company that provides diabetics with several products to monitor their blood sugar levels. Jefferies and H.C. Wainwright covered the stock in 2023, rating the shares as Underperform and Buy, respectively.
Insider Monkey’s September 2023 survey covering 910 hedge funds revealed that nine had invested in Senseonics Holdings, Inc. (NYSE:SENS). Mike Masters’s Masters Capital Management was the largest shareholder, owning $4.2 million worth of shares.
Follow Senseonics Holdings Inc.
Follow Senseonics Holdings Inc.
1. Cassava Sciences, Inc. (NASDAQ:SAVA)
Latest Average Analyst Share Price Target: $99.5
Latest Share Price Percentage Upside: 315.62%
Cassava Sciences, Inc. (NASDAQ:SAVA) is a biotechnology company that is focusing on developing a treatment for Alzheimer’s disease. The firm’s shares rocketed by 17% in December 2023 after it shook things up and announced three new board members.
Six out of the 910 hedge funds covered by Insider Monkey’s research had held a stake in the company during Q3 2023. Out of these, the biggest investor was Ian Cumming and Joseph Steinberg’s Leucadia National since it held a $3.9 million stake.
Follow Cassava Sciences Inc (NASDAQ:SAVA)
Follow Cassava Sciences Inc (NASDAQ:SAVA)
Disclosure: None. You can also take a look at 11 Best Technology Dividend Stocks To Buy and 10 Best Sectors To Invest In Long-Term.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
